— Know what they know.
Not Investment Advice
Also trades as: LLY.DE (XETRA) · $vol 2M · LLY.SW (SIX) · $vol 0M

LLY NYSE

Eli Lilly and Company
1W: +3.7% 1M: +13.1% 3M: +3.2% YTD: -3.4% 1Y: +40.0% 3Y: +142.9% 5Y: +454.8%
$1,065.00
+23.35 (+2.24%)
 
Weekly Expected Move ±6.5%
$874 $940 $1005 $1070 $1136
NYSE · Healthcare · Drug Manufacturers - General · Alpha Radar Strong Buy · Power 78 · $1.00T mcap · 847M float · 0.364% daily turnover · Short 39% of daily vol

📊 Key Metrics

TTM
$72B
Revenue
+47.4% YoY
$25B
Net Income
+127.6% YoY
$14B
Free Cash Flow
+1169.5% YoY
81.9%
Gross Margin
44.7%
Op. Margin
37.4%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE124.1%
ROA26.4%
ROIC43.6%

Valuation

P/E37.8
P/B30.6
EV/EBITDA25.9

Leverage

Debt/Equity1.60
Current Ratio1.58
Interest Cov.35.7x

Quality Scores

Piotroski F7/9
Altman Z7.84
Beneish M-1.76

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms